Diagnostic Utility of Human Chorionic Gonadotropin Washout in Cervical Lymph Node Fine-Needle Aspiration for Metastatic Testicular Cancer

• Main Authors: Jamie Kaplan, BS, Helmi Khadra, MD, Andrew B. Sholl, MD, Emad Kandil, MD, MBA
• Format: Article
• Language: English
• Published: Elsevier 2019-05-01
• Series: AACE Clinical Case Reports
• Online Access: http://www.sciencedirect.com/science/article/pii/S2376060520303990

ABSTRACT: Objective: This case report will describe the first adjunct use of directly measuring the concentration of human chorionic gonadotropin (HCG) in fine-needle aspiration (FNA) washout for diagnosing metastatic non-semi-nomatous germ cell tumor (NSGCT) of the testicle in a patient with cervical lymphadenopathy.Methods: We present the clinical, laboratory, imaging, and pathologic findings, along with a review of the literature.Results: A 23-year-old, otherwise healthy man who first presented with left testicular discomfort and swelling was diagnosed with NSGCT after undergoing a left orchiectomy. A few years later, the patient presented with a 2-cm left supraclavicular mass. Upon ultrasound of the thyroid and soft tissues of the neck, a 1-cm left thyroid nodule was revealed, as well as a 2.8-cm left supraclavicular lymph node, which was cystic in nature and worrisome for metastatic disease given the patient's history of metastatic NSGCT. The results of the FNA of the left thyroid nodule were benign, however the results from the supraclavicular mass were nondiagnostic. Due to the nondiagnostic FNA results, another aspiration with cytopathology and HCG evaluation washout was performed. The HCG aspirate came back with a value of 162 mIU/mL, despite the patient's negative serum HCG results.Conclusion: This case demonstrates a novel way to diagnose metastatic testicular germ cell tumors utilizing FNA-HCG washout. Future prospective trials are needed to further elucidate this important finding.Abbreviations: FNA fine-needle aspiration HCG human chorionic gonadotropin NSGCT non-seminomatous germ cell tumor TG thyroglobulin